ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

During the Trading Day
11.61 +0.165 / +1.44%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.71 +0.10 / +0.86%
 
Volume: 40.2K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.3B

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:

Employees

Shareholders

Individual stakeholders29.39%
Other institutional12.69%
Mutual fund holders10.03%

Top Executives

Jonathan J. LewisChief Executive Officer & Director
Kevin G. LafondChief Financial Officer, Treasurer, CAO & VP
J. Kris PiperVice President-Clinical Regulatory & Quality
Francois LebelSVP-Clinical Development & Medical Operations
Caesar J. BelbelSecretary, Chief Legal Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account